FLDM - Flora Growth leads weekly healthcare gainers; Alzheimer's-focused stocks trail

After four back-to-back sessions of gains, the healthcare stocks in the S&P 500 finished ~0.5% higher this week to outperform the ~0.4% loss recorded by the broader index over the past five-day period. A major industry event on Alzheimer’s disease dominated health care news headlines this week while earnings season got underway in full swing. More than doubling in value, Flora Growth (NASDAQ:FLGC) leaped into the category of small cap stocks this week as it became the best performer among health care stocks (with more than $300M market cap and over 100K average daily volume of shares). News about a couple of deals to strengthen its international supply network saw the stock soaring ~159.6% over the past week. Meanwhile, the recently IPO’d healthcare firms Cyteir Therapeutics (NASDAQ:CYT) and Absci, CORP (NASDAQ:ABSI) followed up with ~25.2% and ~24.4% gains respectively. Before the company’s IPO, Absci CEO Sean McClain talked to Seeking Alpha last week  highlighting among other things the

For further details see:

Flora Growth leads weekly healthcare gainers; Alzheimer’s-focused stocks trail